, Tracking Stock Market Picks
Enter Symbol:
Ca Inc. (CA) [hlAlert]

Buy CA
up 45.93 %

Ca Inc. (CA) rated Buy with price target $32 by Needham

Posted on: Wednesday,  Jan 25, 2012  8:25 AM ET by Needham

Needham rated Buy Ca Inc. (NASDAQ: CA) on 01/25/2012. Previously Needham rated Buy Ca Inc. (NASDAQ: CA) on 12/22/2008., when
the stock price was $18.59. Since then, Ca Inc. has gained 45.94% as of 01/22/2016's recent price of $27.13.
If you would have followed the previous Needham's recommendation on CA, you would have gained 45.93% of your investment in 2587 days.

Careside has developed and plans to sell a proprietary blood testing systemcalled the Careside system. It is designed to decentralize laboratoryoperations. The system consists of a testing instrument called the CareSideAnalyzer and disposable test cartridges. It performs blood tests in the same location as the patient, or what is commonly called point-of-care testing. The company's goal is to make decentralized testing with the Careside system the standard for routine and critical care blood testing.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/25/2012 8:25 AM Buy
25.76 32.00
as of 12/31/2012
1 Week down  -1.61 %
1 Month down  -0.81 %
3 Months down  -14.67 %
1 YTD up  8.70 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/27/2011 9:25 AM Buy
21.36 25.00
5/13/2011 8:25 AM Buy
22.53 29.00
12/22/2008 9:25 AM Buy
18.59 22.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy